Title : MicroRNA-214-5p involves in the protection effect of Dexmedetomidine against neurological injury in Alzheimer's disease via targeting the suppressor of zest 12.

Pub. Date : 2022 Jan

PMID : 34715270






6 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 MicroRNA-214-5p involves in the protection effect of Dexmedetomidine against neurological injury in Alzheimer"s disease via targeting the suppressor of zest 12. Dexmedetomidine SUZ12 polycomb repressive complex 2 subunit Mus musculus
2 Dexmedetomidine (Dex) has been evidenced to exert neuroprotective effects on multiple neurological diseases, while the function of microRNA(miR)-214-5p on Dex-mediated AD progression via targeting the suppressor of zest 12 (SUZ12) remains unclear. Dexmedetomidine SUZ12 polycomb repressive complex 2 subunit Mus musculus
3 Dex administration reduced the apoptosis of hippocampal neurons, the contents of serum inflammatory factor and oxidative stress, and attenuated the cognitive impairment of AD mice accompanied by up-regulated miR-214-5p and down-regulated SUZ12, and the overexpression of miR-214-5p or reduction of SUZ12 could effectively enhance the Dex-treated effects on AD mice. Dexmedetomidine SUZ12 polycomb repressive complex 2 subunit Mus musculus
4 Dex administration reduced the apoptosis of hippocampal neurons, the contents of serum inflammatory factor and oxidative stress, and attenuated the cognitive impairment of AD mice accompanied by up-regulated miR-214-5p and down-regulated SUZ12, and the overexpression of miR-214-5p or reduction of SUZ12 could effectively enhance the Dex-treated effects on AD mice. Dexmedetomidine SUZ12 polycomb repressive complex 2 subunit Mus musculus
5 Dex administration reduced the apoptosis of hippocampal neurons, the contents of serum inflammatory factor and oxidative stress, and attenuated the cognitive impairment of AD mice accompanied by up-regulated miR-214-5p and down-regulated SUZ12, and the overexpression of miR-214-5p or reduction of SUZ12 could effectively enhance the Dex-treated effects on AD mice. Dexmedetomidine SUZ12 polycomb repressive complex 2 subunit Mus musculus
6 CONCLUSION: Dex may have a potential neuroprotective effect on AD via the miR-214-5p/SUZ12 axis. Dexmedetomidine SUZ12 polycomb repressive complex 2 subunit Mus musculus